1. Market Research
  2. > Pathology Industry

Prostate Cancer Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Molecular Diagnostic, Therapeutics, Healthcare, Biomarker, Biopsy Device, Vaccine, Cancer Diagnostic, Chemotherapy, Pharmaceutical, Radiation Therapy, Therapy, Carotenoid, Diagnostic, Hormone, Radiopharmaceutical, Transdermal Drug Delivery.


 
1-10 of about 100 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Global Prostate Cancer Partnering 2010 to 2016

Global Prostate Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, ...

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

 Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2016

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive ...

 Metastatic Prostate Cancer-Pipeline Insights, 2016

Metastatic Prostate Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Metastatic Prostate Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Prostate ...

Prostate Cancer - Pipeline Review, H2 2015

Prostate Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H2 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) ...

United States Medicine in Prostate Cancer Industry 2015 Market Research Report

United States Medicine in Prostate Cancer Industry 2015 Market Research Report

  • $ 3 800
  • Industry report
  • November 2015
  • by QY Research Group

Summary The United States Medicine in Prostate Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Medicine in Prostate Cancer industry. The report ...

About 3 300 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    25 pages
  • Cancer  

    Prostate Cancer  

    Oncology  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.